加快药物伙伴关系®精神分裂症 (AMP® SCZ):全球最大的前性队列研究临床精神病高风险的理由和研究设计
Cassandra M J Wannan1,2, Barnaby Nelson1,2, Jean Addington3
1Centre for Youth Mental Health, The University of Melbourne, Parkville, VIC, Australia.
Schizophrenia bulletin
|March 7, 2024
概括
加快药物伙伴关系精神分裂症 (AMP SCZ) 是一项全球研究,预测精神病风险,并为临床高风险 (CHR) 个体开发新的治疗方法. 这项研究旨在通过先进的算法和新的干预措施来改善CHR个人的结果.
科学领域:
- 精神病学和神经科学 精神病学和神经科学
- 基因组学和精准医学精准医学
- 数字卫生技术数字卫生技术
背景情况:
- 精神分裂症仍然是一个重大的公共卫生挑战,对有效干预的需求尚未得到满足.
- 识别患有精神病临床高风险 (CHR) 的个体对于早期干预和治疗开发至关重要.
- 对于CHR个体的当前治疗方法需要进步以改善长期结果.
研究的目的:
- 建立最大的国际合作,预测CHR个人的精神病轨迹.
- 为CHR个体开发新的药理干预措施.
- 通过全面的数据分析,推进精神病的理解和治疗.
主要方法:
- 协调来自13个国家的43个国际站点的数据.
- 收集多模式数据,包括临床,环境,认知,神经成像,电生理学,生物标本,语音,面部表情和数字健康技术 (智能手机调查,被动传感,行为摄影).
- 在两年时间内,分析了大约2000名CHR个体和640名健康对照组的数据.
主要成果:
- 该研究旨在产生用于预测精神病风险和治疗反应的算法.
- 将收集和分析多模式生物标记数据,以确定新的治疗点.
- 全球范围和协调方法将促进新治疗方法的开发.
结论:
- AMP SCZ有望催化CHR患者的新治疗方法的开发.
- 这项研究的结果将解决精神病的关键未满足的临床和公共卫生需求.
- 这项大规模的国际努力将推动精神病学领域的精准医学方法.
相关概念视频
01:26Psychosis: Goals of Pharmacotherapy
128
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
128
01:28Drug Therapy
43
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
43
01:28Psychosis and Antipsychotic Drugs: Overview
253
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
253
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
126
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
126
01:29Psychological and Sociocultural Causes of Schizophrenia
86
Schizophrenia, a complex psychiatric disorder, has been historically misunderstood. Early psychological theories attributed its origins to childhood trauma and unresponsive parenting. However, contemporary research largely rejects these notions, favoring the vulnerability-stress hypothesis. This model proposes that individuals with a genetic predisposition to schizophrenia may develop the disorder following exposure to significant environmental stressors. Notably, studies on high-risk...
86
01:23Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
137
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
137